How ephedrine escaped regulation in the United States: a historical review of misuse and associated policy
- PMID:20685002
- DOI: 10.1016/j.healthpol.2010.07.007
How ephedrine escaped regulation in the United States: a historical review of misuse and associated policy
Abstract
Objective: Ephedrine is not only efficacious in the treatment of numerous ailments, but also has a long history of misuse. Research was needed to examine ephedrine policy over time in order to determine potential regulatory flaws that allowed misuse to continue.
Methods: This review is based on primary literature derived from systematic searches of historical and scientific archives, as well as grey literature.
Results: Ephedrine managed to pass through numerous regulatory loopholes within seventy years. Despite warnings of misuse over the latter half of the century, ephedrine, and its herbal source, ephedra, were regulated in a piecemeal fashion and remained easily available to the public. Health authorities have struggled to control ephedrine, as an amphetamine "look-alike," as a methamphetamine precursor, as a dietary supplement, and as a medication. Despite being a potentially dangerous stimulant, under-regulation was perhaps more problematic than the substance itself.
Conclusions: Tighter control of all ephedrine products, drugs and dietary supplements alike, might have prevented adverse outcomes and allowed this substance to remain available in a safer manner. Stringent regulation of all ephedrine products is necessary to prevent misuse and to protect the public's health.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.Food and Drug Administration, HHS.Food and Drug Administration, HHS.Fed Regist. 2004 Feb 11;69(28):6787-854.Fed Regist. 2004.PMID:14968803
- History and overview of DSHEA.Dickinson A.Dickinson A.Fitoterapia. 2011 Jan;82(1):5-10. doi: 10.1016/j.fitote.2010.09.001. Epub 2010 Sep 17.Fitoterapia. 2011.PMID:20837113Review.
- American roulette--contaminated dietary supplements.Cohen PA.Cohen PA.N Engl J Med. 2009 Oct 15;361(16):1523-5. doi: 10.1056/NEJMp0904768. Epub 2009 Oct 7.N Engl J Med. 2009.PMID:19812394No abstract available.
- The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.Weissmann G.Weissmann G.FASEB J. 2009 May;23(5):1279-82. doi: 10.1096/fj.09-0501ufm.FASEB J. 2009.PMID:19406845No abstract available.
- A historical analysis of public health, the law, and stigmatized social groups: the need for both obesity and weight bias legislation.Pomeranz JL.Pomeranz JL.Obesity (Silver Spring). 2008 Nov;16 Suppl 2:S93-103. doi: 10.1038/oby.2008.452.Obesity (Silver Spring). 2008.PMID:18978770Review.
Cited by
- Natural Sympathomimetic Drugs: From Pharmacology to Toxicology.Costa VM, Grando LGR, Milandri E, Nardi J, Teixeira P, Mladěnka P, Remião F, On Behalf Of The Oemonom.Costa VM, et al.Biomolecules. 2022 Nov 30;12(12):1793. doi: 10.3390/biom12121793.Biomolecules. 2022.PMID:36551221Free PMC article.Review.
- The Safety and Efficacy ofCitrus aurantium (Bitter Orange) Extracts andp-Synephrine: A Systematic Review and Meta-Analysis.Koncz D, Tóth B, Bahar MA, Roza O, Csupor D.Koncz D, et al.Nutrients. 2022 Sep 28;14(19):4019. doi: 10.3390/nu14194019.Nutrients. 2022.PMID:36235672Free PMC article.
- Regulatory analysis on the medical use of ephedrine-related products in Taiwan.Yu WN, Wang LH, Cheng HW.Yu WN, et al.J Food Drug Anal. 2018 Apr;26(2):481-486. doi: 10.1016/j.jfda.2017.11.002. Epub 2017 Dec 2.J Food Drug Anal. 2018.PMID:29567216Free PMC article.Review.
- Development of a Genus-Universal Nucleotide Signature for the Identification and Supervision ofEphedra-Containing Products.Wang G, Bai X, Chen X, Ren Y, Han J.Wang G, et al.Molecules. 2022 Apr 6;27(7):2342. doi: 10.3390/molecules27072342.Molecules. 2022.PMID:35408741Free PMC article.
- Unhealthy weight control practices: culprits and clinical recommendations.Ferraro ZM, Patterson S, Chaput JP.Ferraro ZM, et al.Clin Med Insights Endocrinol Diabetes. 2015 Feb 17;8:7-11. doi: 10.4137/CMED.S23060. eCollection 2015.Clin Med Insights Endocrinol Diabetes. 2015.PMID:25733947Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources